These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 19997085

  • 1. ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.
    Stone DJ, Molony C, Suver C, Schadt EE, Potter WZ.
    Pharmacogenomics J; 2010 Jun; 10(3):161-4. PubMed ID: 19997085
    [No Abstract] [Full Text] [Related]

  • 2. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [Abstract] [Full Text] [Related]

  • 3. Allele predicted accelerated rate of cognitive decline in Alzheimer's disease.
    Burke D.
    West J Med; 1999 Jul; 171(1):23. PubMed ID: 10483340
    [No Abstract] [Full Text] [Related]

  • 4. [Frequency of the APOE-4 allele in Alzheimer's disease and its variation with age in Asturias (Spain)].
    Alvarez V, Alvarez R, Peña J, Lahoz CH, Martínez C, Menéndez-Guisasola L, Salas-Puig J, Morís G, Uría D, Menes BB, Ribacoba R, Vidal JA, Coto E.
    Med Clin (Barc); 1999 Oct 16; 113(12):441-3. PubMed ID: 10570509
    [Abstract] [Full Text] [Related]

  • 5. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H.
    Brain; 2008 May 16; 131(Pt 5):1252-8. PubMed ID: 18334538
    [Abstract] [Full Text] [Related]

  • 6. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J, Steijns LS, Teepen JL, Noback WJ, Klaverwijden G.
    Tijdschr Gerontol Geriatr; 1996 Apr 16; 27(2):73-7. PubMed ID: 8669075
    [Abstract] [Full Text] [Related]

  • 7. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT.
    Ann Neurol; 1996 Jan 16; 39(1):62-70. PubMed ID: 8572669
    [Abstract] [Full Text] [Related]

  • 8. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
    Lai MK, Tsang SW, Garcia-Alloza M, Minger SL, Nicoll JA, Esiri MM, Wong PT, Chen CP, Ramírez MJ, Francis PT.
    Neurobiol Dis; 2006 Jun 16; 22(3):555-61. PubMed ID: 16473016
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA, Oulhaj A, de Jager CA, Williams JH.
    Neurology; 2005 Dec 27; 65(12):1888-93. PubMed ID: 16380608
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease.
    Kowalska A, Florczak J, Pruchnik-Wolińska D, Kraszewski A, Wender M.
    Arch Immunol Ther Exp (Warsz); 1998 Dec 27; 46(3):177-81. PubMed ID: 9704150
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.
    Huriletemuer, Wang B, Wang J, Wang G, Zhang C, Zhao S, Zhou S, Ma X, Wang de S.
    J Neurol Sci; 2010 Jan 15; 288(1-2):167-9. PubMed ID: 19819468
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of genetic variation of apolipoprotein E in Alzheimer's disease].
    Martínez Lage JM.
    Med Clin (Barc); 1999 Oct 16; 113(12):449-51. PubMed ID: 10570512
    [No Abstract] [Full Text] [Related]

  • 16. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.
    Lucotte G, Aouizérate A, Gérard N, Turpin JC, Landais P.
    Am J Med Genet; 1995 Dec 18; 60(6):566-9. PubMed ID: 8825898
    [Abstract] [Full Text] [Related]

  • 17. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA, Hermann B, La Rue A.
    J Geriatr Psychiatry Neurol; 2005 Dec 18; 18(4):245-9. PubMed ID: 16306248
    [Abstract] [Full Text] [Related]

  • 18. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.
    Methods Find Exp Clin Pharmacol; 1999 Nov 18; 21(9):633-44. PubMed ID: 10669911
    [Abstract] [Full Text] [Related]

  • 19. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
    Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A, Oluwole SO, Komolafe O, Hall KS, Unverzagt FW.
    Ann Neurol; 1995 Sep 18; 38(3):463-5. PubMed ID: 7668835
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.